New drug trial opens for Tough-to-Treat cancers
NCT ID NCT07374848
First seen Feb 01, 2026 · Last updated Apr 14, 2026 · Updated 10 times
Summary
This early-stage study is testing a new experimental drug called ZL-6201 in adults with advanced sarcoma and other solid tumors that have spread or cannot be removed by surgery. The main goal is to find a safe dose and understand how the body processes the drug, while also looking for early signs that it might help control the cancer. Researchers will enroll about 180 participants who have already tried a few other treatments without success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zai Lab Site 02006
RECRUITINGFairfax, Virginia, 22031, United States
Contact
-
Zai Lab Site 02026
RECRUITINGSarasota, Florida, 34232, United States
Contact
Conditions
Explore the condition pages connected to this study.